업스트림 바이오프로세싱 시장 규모, 점유율, 동향 분석 리포트 : 제품별, 워크플로우별, 사용 유형별, 모드별, 지역별, 부문 예측(2024-2030년)

Upstream Bioprocessing Market Growth & Trends:

The global upstream bioprocessing market size is expected to reach USD 59.24 billion by 2030, registering a CAGR of 14.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. Commercial success and wide acceptance of biopharmaceuticals have provided lucrative growth avenues to several in house as well as contract manufacturing biopharmaceutical companies. Furthermore, a confluence of factors, such as high demand for biosimilars and biologics, launch of improved cost-effective technologies, and growing acceptance of single-use systems have driven the revenue performance of the market.

Start-ups and new market entrants often face budget constraints while establishing new biomanufacturing plants. Thus, these entities expand their biotherapeutics portfolio by outsourcing the production process to contract services, thereby aiding in revenue growth for upstream bioprocessing services.

Continuous upstream bioprocessing has greatly benefited the bioprocessing industry. Rising implementation of methods, such as acoustic wave technology and continuous centrifugation, for clarification of bioreactor cultures tends to minimize the clarification burden. This, in turn, increases the cell-culture densities, consequently resulting in efficient upstream processes.

Ongoing advancements in cell line productivity with respect to protein expression and clone screening are expected to result in the fastest CAGR of cell culture products over the forecast period. Cell culture is considered as the most challenging and crucial step in upstream bioprocessing, and thus demands more attention with respect to technological intricacies, resulting in the largest share in the upstream bioprocessing market.

Factors such as multi-use systems incur one-time investment, are applicable for larger bioprocessing volumes and maintain the pH and oxygen accurately resulting in high usage rate of these systems. However, a paradigm shift from conventional stainless-steel bioreactors to single-use bioreactor systems has attributed to the lucrative growth of the single-use segment.

Key market players are adopting strategic initiatives, such as novel product developments, mutually beneficial partnerships, agreements, and geographical expansion to reinforce their market presence. For instance, in February 2019, Danaher Corporation signed an agreement to acquire the Biopharma business of GE Life Sciences. The acquisition broadened Danaher's market presence with the addition of GE Biopharma's cell culture media, single-use technologies, development instrumentation, and consumables to its existing portfolio.

Upstream Bioprocessing Market Report Highlights:

• High availability of bioreactors and continuous launches of single-use bioreactors by the key market players can be attributed to the remarkable revenue share of the bioreactors segment
• Presence of well-established biopharmaceutical manufacturing firms capable of performing in-house bioproduction has led to the maximum revenue share of this segment
• The outsourced segment is expected to grow at the highest CAGR over the forecast period, owing to increase in investments and expansion of manufacturing capabilities through the integration of single-use systems in the plants by CMOs
• North America dominated the market and accounted for a share of 36.2% in 2023 as a result of the continuous innovations in biotechnology and rising preferences for biopharmaceuticals in the region. Moreover, the presence of substantial in-house biopharmaceutical manufacturers coupled with numerous investments in the U.S. biologics market has driven the growth
• Asia Pacific is expected to be the fastest-growing region in the market and is expected to grow at a CAGR of 17.4% during the forecast period due to growing awareness about the rapid analytical methods that can be used for in-process control during the upstream workflows

Table of Contents

Chapter 1. Upstream Bioprocessing Market: Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Product
  • 1.1.2. Workflow
  • 1.1.3. Use Type
  • 1.1.4. Mode
  • 1.1.5. Regional scope
  • 1.1.6. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Upstream Bioprocessing Market: Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Workflow outlook
  • 2.2.3. Use type outlook
  • 2.2.4. Mode outlook
  • 2.2.5. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Upstream Bioprocessing Market: Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
• 3.3. Upstream Bioprocessing Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Upstream Bioprocessing Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Upstream Bioprocessing Market Product Movement Analysis
• 4.3. Global Upstream Bioprocessing Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Bioreactors/Fermenters
  • 4.4.1. Bioreactors/fermenters market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Cell Culture Products
  • 4.5.1. Cell Culture Products market estimates and forecasts 2018 to 2030 (USD Million)
• 4.6. Filters
  • 4.6.1. Filters market estimates and forecasts 2018 to 2030 (USD Million)
• 4.7. Bioreactors Accessories
  • 4.7.1. Bioreactors accessories market estimates and forecasts 2018 to 2030 (USD Million)
• 4.8. Bags & Containers
  • 4.8.1. Bags & containers market estimates and forecasts 2018 to 2030 (USD Million)
• 4.9. Others
  • 4.9.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Upstream Bioprocessing Market: Workflow Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Upstream Bioprocessing Market Workflow Movement Analysis
• 5.3. Global Upstream Bioprocessing Market Size & Trend Analysis, by Workflow, 2018 to 2030 (USD Million)
• 5.4. Media Preparation
  • 5.4.1. Media preparation market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Cell Culture
  • 5.5.1. Cell culture market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Cell Separation
  • 5.6.1. Cell separation market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Upstream Bioprocessing Market: Use Type Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Upstream Bioprocessing Market Use Type Movement Analysis
• 6.3. Global Upstream Bioprocessing Market Size & Trend Analysis, by Use Type, 2018 to 2030 (USD Million)
• 6.4. Multi-use
  • 6.4.1. Multi-use market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Single-use
  • 6.5.1. Single-use market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Upstream Bioprocessing Market: Mode Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global Upstream Bioprocessing Market Mode Movement Analysis
• 7.3. Global Upstream Bioprocessing Market Size & Trend Analysis, by Mode, 2018 to 2030 (USD Million)
• 7.4. In-house
  • 7.4.1. In-house market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Outsourced
  • 7.5.1. Outsourced market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Upstream Bioprocessing Market: Regional Estimates & Trend Analysis

• 8.1. Regional Market Share Analysis, 2023 & 2030
• 8.2. Regional Market Dashboard
• 8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 8.4. North America
  • 8.4.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.2. U.S.
    • 8.4.2.1. Key country dynamics
    • 8.4.2.2. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.2.3. Competitive scenario
    • 8.4.2.4. Regulatory framework
  • 8.4.3. Canada
    • 8.4.3.1. Key country dynamics
    • 8.4.3.2. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.3.3. Competitive scenario
    • 8.4.3.4. Regulatory framework
• 8.5. Europe
  • 8.5.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.2. UK
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.2.3. Competitive scenario
    • 8.5.2.4. Regulatory framework
  • 8.5.3. Germany
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.3.3. Competitive scenario
    • 8.5.3.4. Regulatory framework
  • 8.5.4. France
    • 8.5.4.1. Key country dynamics
    • 8.5.4.2. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.4.3. Competitive scenario
    • 8.5.4.4. Regulatory framework
  • 8.5.5. Italy
    • 8.5.5.1. Key country dynamics
    • 8.5.5.2. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.5.3. Competitive scenario
    • 8.5.5.4. Regulatory framework
  • 8.5.6. Spain
    • 8.5.6.1. Key country dynamics
    • 8.5.6.2. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.6.3. Competitive scenario
    • 8.5.6.4. Regulatory framework
  • 8.5.7. Denmark
    • 8.5.7.1. Key country dynamics
    • 8.5.7.2. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.7.3. Competitive scenario
    • 8.5.7.4. Regulatory framework
  • 8.5.8. Norway
    • 8.5.8.1. Key country dynamics
    • 8.5.8.2. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.8.3. Competitive scenario
    • 8.5.8.4. Regulatory framework
  • 8.5.9. Sweden
    • 8.5.9.1. Key country dynamics
    • 8.5.9.2. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.9.3. Competitive scenario
    • 8.5.9.4. Regulatory framework
• 8.6. Asia Pacific
  • 8.6.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.2. Japan
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.2.3. Competitive scenario
    • 8.6.2.4. Regulatory framework
  • 8.6.3. China
    • 8.6.3.1. Key country dynamics
    • 8.6.3.2. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.3.3. Competitive scenario
    • 8.6.3.4. Regulatory framework
  • 8.6.4. India
    • 8.6.4.1. Key country dynamics
    • 8.6.4.2. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.4.3. Competitive scenario
    • 8.6.4.4. Regulatory framework
  • 8.6.5. Australia
    • 8.6.5.1. Key country dynamics
    • 8.6.5.2. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.5.3. Competitive scenario
    • 8.6.5.4. Regulatory framework
  • 8.6.6. South Korea
    • 8.6.6.1. Key country dynamics
    • 8.6.6.2. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.6.3. Competitive scenario
    • 8.6.6.4. Regulatory framework
  • 8.6.7. Thailand
    • 8.6.7.1. Key country dynamics
    • 8.6.7.2. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.7.3. Competitive scenario
    • 8.6.7.4. Regulatory framework
• 8.7. Latin America
  • 8.7.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.2. Brazil
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.2.3. Competitive scenario
    • 8.7.2.4. Regulatory framework
  • 8.7.3. Mexico
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.3.3. Competitive scenario
    • 8.7.3.4. Regulatory framework
  • 8.7.4. Argentina
    • 8.7.4.1. Key country dynamics
    • 8.7.4.2. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.4.3. Competitive scenario
    • 8.7.4.4. Regulatory framework
• 8.8. MEA
  • 8.8.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8.2. South Africa
    • 8.8.2.1. Key country dynamics
    • 8.8.2.2. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.2.3. Competitive scenario
    • 8.8.2.4. Regulatory framework
  • 8.8.3. Saudi Arabia
    • 8.8.3.1. Key country dynamics
    • 8.8.3.2. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.3.3. Competitive scenario
    • 8.8.3.4. Regulatory framework
  • 8.8.4. UAE
    • 8.8.4.1. Key country dynamics
    • 8.8.4.2. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.4.3. Competitive scenario
    • 8.8.4.4. Regulatory framework
  • 8.8.5. Kuwait
    • 8.8.5.1. Key country dynamics
    • 8.8.5.2. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.5.3. Competitive scenario
    • 8.8.5.4. Regulatory framework

Chapter 9. Competitive Landscape

• 9.1. Company/Competition Categorization
• 9.2. Strategy Mapping
• 9.3. Company Market Position Analysis, 2023
• 9.4. Company Profiles/Listing
  • 9.4.1. Thermo Fisher Scientific, Inc.
    • 9.4.1.1. Company overview
    • 9.4.1.2. Financial performance
    • 9.4.1.3. Product benchmarking
    • 9.4.1.4. Strategic initiatives
  • 9.4.2. Merck KGaA
    • 9.4.2.1. Company overview
    • 9.4.2.2. Financial performance
    • 9.4.2.3. Product benchmarking
    • 9.4.2.4. Strategic initiatives
  • 9.4.3. Corning Incorporated
    • 9.4.3.1. Company overview
    • 9.4.3.2. Financial performance
    • 9.4.3.3. Product benchmarking
    • 9.4.3.4. Strategic initiatives
  • 9.4.4. Sartorius AG
    • 9.4.4.1. Company overview
    • 9.4.4.2. Financial performance
    • 9.4.4.3. Product benchmarking
    • 9.4.4.4. Strategic initiatives
  • 9.4.5. Eppendorf AG
    • 9.4.5.1. Company overview
    • 9.4.5.2. Financial performance
    • 9.4.5.3. Product benchmarking
    • 9.4.5.4. Strategic initiatives
  • 9.4.6. Danaher
    • 9.4.6.1. Company overview
    • 9.4.6.2. Financial performance
    • 9.4.6.3. Product benchmarking
    • 9.4.6.4. Strategic initiatives
  • 9.4.7. Boehringer Ingelheim GmbH
    • 9.4.7.1. Company overview
    • 9.4.7.2. Financial performance
    • 9.4.7.3. Product benchmarking
    • 9.4.7.4. Strategic initiatives
  • 9.4.8. Applikon Biotechnology
    • 9.4.8.1. Company overview
    • 9.4.8.2. Financial performance
    • 9.4.8.3. Product benchmarking
    • 9.4.8.4. Strategic initiatives
  • 9.4.9. PBS Biotech, Inc.
    • 9.4.9.1. Company overview
    • 9.4.9.2. Financial performance
    • 9.4.9.3. Product benchmarking
    • 9.4.9.4. Strategic initiatives
  • 9.4.10. Lonza
    • 9.4.10.1. Company overview
    • 9.4.10.2. Financial performance
    • 9.4.10.3. Product benchmarking
    • 9.4.10.4. Strategic initiatives
  • 9.4.11. VWR International, LLC
    • 9.4.11.1. Company overview
    • 9.4.11.2. Financial performance
    • 9.4.11.3. Product benchmarking
    • 9.4.11.4. Strategic initiatives
  • 9.4.12. Meissner Filtration Products, Inc.
    • 9.4.12.1. Company overview
    • 9.4.12.2. Financial performance
    • 9.4.12.3. Product benchmarking
    • 9.4.12.4. Strategic initiatives
  • 9.4.13. Repligen Corporation
    • 9.4.13.1. Company overview
    • 9.4.13.2. Financial performance
    • 9.4.13.3. Product benchmarking
    • 9.4.13.4. Strategic initiatives
  • 9.4.14. Entegris
    • 9.4.14.1. Company overview
    • 9.4.14.2. Financial performance
    • 9.4.14.3. Product benchmarking
    • 9.4.14.4. Strategic initiatives
  • 9.4.15. Kuhner AG
    • 9.4.15.1. Company overview
    • 9.4.15.2. Financial performance
    • 9.4.15.3. Product benchmarking
    • 9.4.15.4. Strategic initiatives